KRMD vs. OSUR, TMCI, NVRO, SGHT, CERS, GUTS, TCMD, LUNG, OBIO, and SKIN
Should you be buying KORU Medical Systems stock or one of its competitors? The main competitors of KORU Medical Systems include OraSure Technologies (OSUR), Treace Medical Concepts (TMCI), Nevro (NVRO), Sight Sciences (SGHT), Cerus (CERS), Fractyl Health (GUTS), Tactile Systems Technology (TCMD), Pulmonx (LUNG), Orchestra BioMed (OBIO), and Beauty Health (SKIN). These companies are all part of the "surgical & medical instruments" industry.
KORU Medical Systems (NASDAQ:KRMD) and OraSure Technologies (NASDAQ:OSUR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, community ranking, analyst recommendations, risk and media sentiment.
KORU Medical Systems currently has a consensus price target of $3.50, indicating a potential upside of 57.66%. OraSure Technologies has a consensus price target of $6.63, indicating a potential upside of 41.26%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, research analysts clearly believe KORU Medical Systems is more favorable than OraSure Technologies.
In the previous week, OraSure Technologies' average media sentiment score of 1.67 beat KORU Medical Systems' score of 0.00 indicating that OraSure Technologies is being referred to more favorably in the news media.
58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 93.5% of OraSure Technologies shares are owned by institutional investors. 25.6% of KORU Medical Systems shares are owned by company insiders. Comparatively, 3.4% of OraSure Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
OraSure Technologies has a net margin of 7.50% compared to KORU Medical Systems' net margin of -45.24%. OraSure Technologies' return on equity of 7.68% beat KORU Medical Systems' return on equity.
OraSure Technologies received 512 more outperform votes than KORU Medical Systems when rated by MarketBeat users. Likewise, 69.72% of users gave OraSure Technologies an outperform vote while only 60.00% of users gave KORU Medical Systems an outperform vote.
KORU Medical Systems has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Comparatively, OraSure Technologies has a beta of 0.14, meaning that its stock price is 86% less volatile than the S&P 500.
OraSure Technologies has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
OraSure Technologies beats KORU Medical Systems on 11 of the 17 factors compared between the two stocks.
Get KORU Medical Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for KRMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding KRMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
KORU Medical Systems Competitors List
Related Companies and Tools
